GLP - TZ2

East Cobb Wellness partners with U.S.-based, state-licensed pharmacies to provide compounded GLP-1 + GIP (tirzepatide) injections, custom-formulated to support effective weight loss, enhance metabolic health, and boost energy.

• Direct from US-based and Licensed Pharmacies.
  
• Order up to six months’ supply at once.
   

Prospective Benefits:

• Significant Weight Loss: Clinical trials have demonstrated that use93rs can achieve substantial weight reduction (up to 20.9% in some studies), often exceeding results from other medications.
• Improved Blood Sugar Control: Used alongside diet and exercise, it reduces 
  levels in patients with type 2 diabetes by promoting insulin release and reducing glucagon
• Cardiovascular & Heart Health: Research indicates it can lower the risk of death or worsening heart failure in patients with obesity and preserved ejection fraction. It also helps improve lipid profiles.
• Appetite Suppression & Satiety: By targeting brain receptors that regulate hunger, it significantly decreases appetite, increases feelings of fullness, and slows gastric emptying, leading to lower calorie intake.
• Reduced Inflammation: It may help manage chronic inflammation by decreasing pro-inflammatory cytokines.
• Treatment for Co-morbidities: It is used to treat moderate to severe obstructive sleep apnea (OSA) in patients with obesity
  

GLP - RT3

RT-3 is an investigational triple-agonist medication (targeting GIP, GLP-1, and glucagon receptors) that offers potent,, sustained weight loss, with clinical trials showing up to 24% body weight reduction in 48 weeks. It also can improve metabolic health, enhance glycemic control, reduce liver fat and help lower blood pressure.
 

Prospective Benefits:

• Significant Weight Loss: In a 48-week phase 2 study, participants on higher doses lost 22–24% of their body weight, with 60–82% of patients achieving a 15% reduction.
  
  
• Triple-Action Mechanism: Unlike dual-agonists (like tirzepatide) or GLP-1s (like semaglutide), it targets GLP-1, GIP, and glucagon receptors, enhancing calorie burning (via glucagon) alongside appetite suppression.
  
  
• Metabolic & Cardiovascular Improvement: Retatrutide significantly lowers fasting glucose and HbA1c, improves blood pressure, and reduces waist circumference.
  
  
• Reduction of Liver Fat: Studies indicate potential for reversing metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as fatty liver disease.
  
  
• Improved Quality of Life: Users reported reduced food cravings and increased, stable energy, with improved physical and emotional well-being.